Emerging Infectious Diseases (Aug 2021)

Epidemiology and Spatial Emergence of Anaplasmosis, New York, USA, 2010‒2018

  • Alexis Russell,
  • Melissa Prusinski,
  • Jamie Sommer,
  • Collin O’Connor,
  • Jennifer White,
  • Richard Falco,
  • John Kokas,
  • Vanessa Vinci,
  • Wayne Gall,
  • Keith Tober,
  • Jamie Haight,
  • JoAnne Oliver,
  • Lisa Meehan,
  • Lee Ann Sporn,
  • Dustin Brisson,
  • P. Bryon Backenson

DOI
https://doi.org/10.3201/eid2708.210133
Journal volume & issue
Vol. 27, no. 8
pp. 2154 – 2162

Abstract

Read online

Human granulocytic anaplasmosis, a tickborne disease caused by the bacterium Anaplasma phagocytophilum, was first identified during 1994 and is now an emerging public health threat in the United States. New York state (NYS) has experienced a recent increase in the incidence of anaplasmosis. We analyzed human case surveillance and tick surveillance data collected by the NYS Department of Health for spatiotemporal patterns of disease emergence. We describe the epidemiology and growing incidence of anaplasmosis cases reported during 2010–2018. Spatial analysis showed an expanding hot spot of anaplasmosis in the Capital Region, where incidence increased >8-fold. The prevalence of A. phagocytophilum increased greatly within tick populations in the Capital Region over the same period, and entomologic risk factors were correlated with disease incidence at a local level. These results indicate that anaplasmosis is rapidly emerging in a geographically focused area of NYS, likely driven by localized changes in exposure risk.

Keywords